http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18809426

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't
endingPage 118
issn 0008-5472
1538-7445
issueIdentifier 1
pageRange 104-118
publicationName Cancer Research
startingPage 104
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_07b9f97a62143c006689bde9da638e21
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d4f0f7216d38415fcfc5d3913239b5f9
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_cc45b1c23079ad589a24b6eb6b8a5a24
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_fd2484f52358775eb44cf931772fba95
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f953efd1353fc234ec3fed8adbeaed7d
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_61fbd4fbefa2824db199af5a4d79988f
bibliographicCitation Alizadeh D, Trad M, Hanke NT, Larmonier CB, Janikashvili N, Bonnotte B, Katsanis E, Larmonier N. Doxorubicin eliminates myeloid-derived suppressor cells and enhances the efficacy of adoptive T-cell transfer in breast cancer. Cancer Res. 2014 Jan 01;74(1):104–18. PMID: 24197130; PMCID: PMC3896092.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_44f1ae98886b697dd6b54ad1bb253a2b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1143a423359e873e66b3f57b68b30085
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cea79b16b7fe910084f6d0b0d7a7f330
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d59454c03cbcf947378b915e5018456f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ff04fa92cfbe38c6a820ac16f76aa485
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fb81eed244d61e489a5c988524fa56de
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2c79f04d786c315a7a1adbe9448dafeb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4270ab83c6c8873dcb855c8c1a73abe4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1098-4598
date 2014-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/24197130
https://pubmed.ncbi.nlm.nih.gov/PMC3896092
https://doi.org/10.1158/0008-5472.can-13-1545
isPartOf https://portal.issn.org/resource/ISSN/0008-5472
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2786
https://portal.issn.org/resource/ISSN/1538-7445
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer
discusses http://id.nlm.nih.gov/mesh/M0006784
http://id.nlm.nih.gov/mesh/M0001348
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D001943Q000188
http://id.nlm.nih.gov/mesh/D013602Q000276
http://id.nlm.nih.gov/mesh/D000903Q000494
http://id.nlm.nih.gov/mesh/D016219Q000379
http://id.nlm.nih.gov/mesh/D022423Q000187
http://id.nlm.nih.gov/mesh/D004317Q000494
http://id.nlm.nih.gov/mesh/D013602Q000187
hasSubjectTerm http://id.nlm.nih.gov/mesh/D001943Q000276
http://id.nlm.nih.gov/mesh/D001943Q000473
http://id.nlm.nih.gov/mesh/D045744
http://id.nlm.nih.gov/mesh/D051379
http://id.nlm.nih.gov/mesh/D022423Q000473
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D022423Q000276
http://id.nlm.nih.gov/mesh/D008807
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D008810
http://id.nlm.nih.gov/mesh/D005260
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_68000b5f90a1d5b5b1a93dbb8aa92d3e
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_29f84c0d894769b14b36c5f43f54153e
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_07f1a4059026e0b860f67d47d4520817
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_805b515085e1ab3a4878bffc5b79e7b6

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13058

Total number of triples: 66.